Clinical Trials
4 trialsNCT07630545 2026-06-05
A Phase I Study in Healthy Volunteers and Parkinson's Disease (PD) Patients.
Mission Therapeutics
Phase 1 Recruiting
NCT01691924 2016-03-08
Study To Assess the Safety and Tolerability of PBF-509 in Male Healthy Volunteers
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Phase 1 Completed
NCT02111330 2016-03-08
Study to Assess the Safety, Tolerability and Pharmacokinetic Profile of PBF -509 (80 mg, 160 mg and 240 mg) "After Multiple Oral Doses" in Healthy Volunteers
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Phase 1 Completed
NCT01698450 2014-10-09
Magnetic Resonance (MR) Guided Functional Ultrasound-Neurosurgery for Movement Disorders
University Children's Hospital, Zurich
Phase 1 Completed